Figure 7 of Song, Mol Vis 2026; 32:354-369.


Figure 7. Galangin (Gal) inhibits cataract formation by suppressing ferroptosis through activation of the Nrf2/SLC7A11/GPX4 signaling pathway. A: Slit-lamp photography was performed to capture ocular images from Aqp5-/-, Aqp5-/- + Fer-1, and Aqp5-/- + Gal mouse groups, and lens opacity scores were evaluated and quantified according to the LOCS II grading system. B: Western blot assays were conducted to detect the protein expression levels of Nrf2, SLC7A11, SLC3A2, and GPX4 in the above experimental groups (n = 3). C: ImageJ software was utilized to quantitatively analyze the relative expression levels of the target proteins. D: Slit-lamp imaging was used to observe lens opacity in Aqp5-/- + Gal and Aqp5-/- + Gal + Bru groups, and the corresponding lens opacity scores were quantified using the LOCS II system. E: Western blot analysis was performed to examine the protein levels of SLC7A11, SLC3A2, and GPX4 in the indicated treatment groups (n = 6). F: ImageJ software was applied to quantify the relative gray values and expression intensities of the target proteins. All quantitative data are presented as the mean ± SD.